Literature DB >> 36268241

Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective.

Luis Antonio Díaz1, Marco Arrese1, Juan Pablo Arab1,2,3.   

Abstract

Entities:  

Year:  2022        PMID： 36268241      PMCID： PMC9577997          DOI： 10.21037/hbsn-22-386

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  15 in total

1.  Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Darren Jun Hao Tan; Cheng Han Ng; Snow Yunni Lin; Xin Hui Pan; Phoebe Tay; Wen Hui Lim; Margaret Teng; Nicholas Syn; Grace Lim; Jie Ning Yong; Jingxuan Quek; Jieling Xiao; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark D Muthiah; Rohit Loomba; Daniel Q Huang
Journal:  Lancet Oncol       Date:  2022-03-04       Impact factor: 41.316

2.   High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.

Authors:  Juan P Arab; Francisco Barrera; Consuelo Gallego; Juan P Valderas; Sergio Uribe; Cristian Tejos; Cristóbal Serrano; Cristóbal Serrano; Álvaro Huete; Jessica Liberona; Pilar Labbé; Teresa Quiroga; Carlos Benítez; Pablo Irarrázaval; Arnoldo Riquelme; Marco Arrese
Journal:  Ann Hepatol       Date:  2016 Sep-Oct       Impact factor: 2.400

3.  NAFLD: Challenges and opportunities to address the public health problem in Latin America.

Authors:  Juan Pablo Arab; Luis Antonio Díaz; Melisa Dirchwolf; Henry E Mark; Jeffrey V Lazarus; Elly Vaughan; Nahum Méndez-Sánchez; Claudia P Oliveira; Adrián Gadano; Marco Arrese
Journal:  Ann Hepatol       Date:  2021-05-15       Impact factor: 2.400

Review 4.  Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.

Authors:  Daniel Geh; Derek M Manas; Helen L Reeves
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

Review 5.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

6.  Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.

Authors:  Alessandro Mantovani; Graziana Petracca; Giorgia Beatrice; Alessandro Csermely; Herbert Tilg; Christopher D Byrne; Giovanni Targher
Journal:  Gut       Date:  2021-03-08       Impact factor: 23.059

Review 7.  The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives.

Authors:  Grazia Pennisi; Ciro Celsa; Antonina Giammanco; Federica Spatola; Salvatore Petta
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

8.  Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.

Authors:  Cristiana Bianco; Oveis Jamialahmadi; Serena Pelusi; Guido Baselli; Paola Dongiovanni; Irene Zanoni; Luigi Santoro; Silvia Maier; Antonio Liguori; Marica Meroni; Vittorio Borroni; Roberta D'Ambrosio; Rocco Spagnuolo; Anna Alisi; Alessandro Federico; Elisabetta Bugianesi; Salvatore Petta; Luca Miele; Umberto Vespasiani-Gentilucci; Quentin M Anstee; Felix Stickel; Jochen Hampe; Janett Fischer; Thomas Berg; Anna Ludovica Fracanzani; Giorgio Soardo; Helen Reeves; Daniele Prati; Stefano Romeo; Luca Valenti
Journal:  J Hepatol       Date:  2020-11-25       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.